"Rectal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the RECTUM.
| Descriptor ID |
D012004
|
| MeSH Number(s) |
C04.588.274.476.411.307.790 C06.301.371.411.307.790 C06.405.249.411.307.790 C06.405.469.491.307.790 C06.405.469.860.180.500
|
| Concept/Terms |
Rectal Neoplasms- Rectal Neoplasms
- Neoplasm, Rectal
- Rectal Neoplasm
- Rectum Neoplasms
- Neoplasm, Rectum
- Rectum Neoplasm
- Rectal Tumors
- Rectal Tumor
- Tumor, Rectal
- Neoplasms, Rectal
Cancer of Rectum- Cancer of Rectum
- Rectum Cancers
- Rectal Cancer
- Cancer, Rectal
- Rectal Cancers
- Rectum Cancer
- Cancer, Rectum
- Cancer of the Rectum
|
Below are MeSH descriptors whose meaning is more general than "Rectal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Rectal Neoplasms".
This graph shows the total number of publications written about "Rectal Neoplasms" by people in this website by year, and whether "Rectal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 0 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 3 | 0 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 1 | 3 |
| 2005 | 4 | 0 | 4 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 4 | 0 | 4 |
| 2012 | 4 | 0 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 7 | 0 | 7 |
| 2015 | 6 | 2 | 8 |
| 2016 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 2 | 4 |
| 2020 | 2 | 2 | 4 |
| 2021 | 4 | 1 | 5 |
| 2022 | 5 | 0 | 5 |
| 2023 | 6 | 0 | 6 |
| 2024 | 9 | 1 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rectal Neoplasms" by people in Profiles.
-
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma. Cancer Rep (Hoboken). 2024 Dec; 7(12):e70037.
-
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer. Radiology. 2024 09; 312(3):e232748.
-
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 08; 22(6):366-375.
-
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer. BMC Cancer. 2024 Jul 26; 24(1):901.
-
Point/Counterpoint #2: Current Clinical Considerations With Nonoperative Management of Rectal Cancer. Cancer J. 2024 Jul-Aug 01; 30(4):256-263.
-
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus. Clin Gastroenterol Hepatol. 2025 May; 23(6):927-945.e2.
-
Neoadjuvant treatment of colorectal cancer: comprehensive review. BJS Open. 2024 May 08; 8(3).
-
Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). BMC Cancer. 2024 Feb 13; 24(1):201.
-
The value of national accreditation program for rectal cancer: A survey of accredited programs and programs seeking accreditation. Surgery. 2024 04; 175(4):1007-1012.
-
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial. JAMA Netw Open. 2024 01 02; 7(1):e2350903.